The role of cathepsin D in the pathophysiology of heart failure and its potentially beneficial properties: a translational approach
Articolo
Data di Pubblicazione:
2019
Abstract:
Aims: Cathepsin D is a ubiquitous lysosomal protease that is primarily secreted due to oxidative stress. The role of circulating cathepsin D in heart failure (HF) is unknown. The aim of this study is to determine the association between circulating cathepsin D levels and clinical outcomes in patients with HF and to investigate the biological settings that induce the release of cathepsin D in HF. Methods and results: Cathepsin D levels were studied in 2174 patients with HF from the BIOSTAT-CHF index study. Results were validated in 1700 HF patients from the BIOSTAT-CHF validation cohort. The primary combined outcome was all-cause mortality and/or HF hospitalizations. Human pluripotent stem cell-derived cardiomyocytes were subjected to hypoxic, pro-inflammatory signalling and stretch conditions. Additionally, cathepsin D expression was inhibited by targeted short hairpin RNAs (shRNA). Higher levels of cathepsin D were independently associated with diabetes mellitus, renal failure and higher levels of interleukin-6 and N-terminal pro-B-type natriuretic peptide (P < 0.001 for all). Cathepsin D levels were independently associated with the primary combined outcome [hazard ratio (HR) per standard deviation (SD): 1.12; 95% confidence interval (CI) 1.02–1.23], which was validated in an independent cohort (HR per SD: 1.23, 95% CI 1.09–1.40). In vitro experiments demonstrated that human stem cell-derived cardiomyocytes released cathepsin D and troponin T in response to mechanical stretch. ShRNA-mediated silencing of cathepsin D resulted in increased necrosis, abrogated autophagy, increased stress-induced metabolism, and increased release of troponin T from human stem cell-derived cardiomyocytes under stress. Conclusions: Circulating cathepsin D levels are associated with HF severity and poorer outcome, and reduced levels of cathepsin D may have detrimental effects with therapeutic potential in HF.
Tipologia CRIS:
1.1 Articolo in rivista
Keywords:
Biomarkers; BIOSTAT-CHF; Cathepsin D; Heart failure; Human stem cell-derived cardiomyocytes
Elenco autori:
Hoes, M. F.; Tromp, J.; Ouwerkerk, W.; Bomer, N.; Oberdorf-Maass, S. U.; Samani, N. J.; Ng, L. L.; Lang, C. C.; van der Harst, P.; Hillege, H.; Anker, S. D.; Metra, M.; van Veldhuisen, D. J.; Voors, A. A.; van der Meer, P.
Link alla scheda completa:
Pubblicato in: